SPG Microstimulator System Market Size, Share, Research Report and Forecast, 2032

What is the projected value for the SPG Microstimulator System Market during 2024 to 2032?

According to the report published by Zion Market Research, the global SPG Microstimulator System Market size was valued at USD 5.82 Billion? in 2023 and is predicted to reach USD 15.49 Billion by the end of 2032. The market is expected to grow with a CAGR of 11.14% during the forecast period. The report analyzes the global SPG Microstimulator System Market’s growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the SPG Microstimulator System Market industry.

Request Free Sample

Global SPG Microstimulator System Market: Overview

The SPG microstimulator system is used for the patients those who are suffering from a chronic headache or a migraine to get a relief from the pain as the standard treatment for these patients are inadequate. The episodic unilateral pain in the periorbital region is termed as cluster headaches. This disease is mainly found in the male population and this headache attacks may last from few minutes to several hours. The treatment using SPG microstimulation systems is an excellent treatment option for the patients which become resistant to triptans. The only SPG microstimulator system that is approved by the US and the European Union is Pulsante System.

Global SPG Microstimulator System Market: Segmentation

The market for SPG microstimulator system is fragmented into indication and end user.

On the basis of indication, the global market is segregated into a migraine, cluster headache, and others.

Depending on the end user, the market is categorized into hospitals, specialty clinics, and ambulatory surgical centers.

Request Free Sample

Global SPG Microstimulator System Market: Growth Factors

The major factor that will contribute towards the SPG microstimulator market growth in the future years is the increasing number of cases of rhinorrhea and chronic cluster headache. There are tests being conducted to check whether SPG microstimulator device can be used as a substitute to occipital nerve stimulation and deep brain stimulation devices. If these studies and test are completed successfully then the deep brain stimulation devices can be replaced, as these devices involve risks and even chances of death. Expanded CE Mark approval is required for the use of the SPG microstimulator system on the patients suffering from chronic headaches. But till now there has been limited product approvals in the US and Europe for SPG microstimulation systems. This is the factor that is restraining the growth of the market for SPG microstimulator systems.

SPG Microstimulator System Market : Report Scope

Global SPG Microstimulator System Market: Regional Analysis

The market for the SPG microstimulator is geographically segmented into Asia-Pacific, the Middle East and Africa, North America, Western Europe, Eastern Europe, and Latin America. It is European region that is dominating the SPG microstimulator systems market. The only key player in SPG microstimulator system market is making effort and is investing rapidly in order to expand its presence in the European region so that they are able to capture the increasing volume of the patients that are suffering from a chronic cluster headache. It is expected the North America will soon become the next largest market for SPG microstimulation system after Europe. In the US, the market player Autonomic Technologies, Inc., is conducting researches and IDE studies for the SPG microstimulation system.

Global SPG Microstimulator System Market: Competitive Players

The only key market player that is right now operating in the SPG microstimulator market is

• Autonomic Technologies, Inc.
• The Pulsante™ SPG Microstimulator System is developed by
• Autonomic Technologies, Inc.

for relieving the acute pain of a cluster headache.

The Global SPG Microstimulator System Market is segmented as follows:

By Indication 

• migraine 
• cluster headache 
• and others 

By end user 

• hospitals 
• specialty clinics 
• and ambulatory surgical centers

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.